The President of the United States, Donald Trump, boasted of the impressive initial results of the trial of the Covid-19 vaccine developed by Modern Inc., which has shown an efficacy of 94.5%. Calling the development of the Covid-19 vaccine as “great discoveries”, the US president said that “great historians” should …
Read More »Modern covid-19 vaccine found 94.5% effective in preventing coronavirus
For the second time this month, more positive news comes from another Covid vaccine candidate. Moderna Inc today announced that the NIH-appointed Data Safety Monitoring Board (DSMB) for the Phase 3 study of mRNA-1273, its candidate vaccine against COVID-19, has shown that the company’s experimental vaccine is 94.5 % effective …
Read More »J&J begins two-dose trial of its Covid-19 vaccine candidate in the UK
Johnson & Johnson launched a new late-stage trial in Britain on Monday to test a two-dose regimen of its experimental Covid-19 vaccine among thousands of volunteers, as the US drugmaker broadens its trials by geography and type. The British arm of the study aims to recruit 6,000 participants from a …
Read More »About 20 COVID-19 vaccines at different stages of development in India: Vardhan
About 20 vaccines are in different stages of development in India, Union Health Minister Harsh Vardhan said on Saturday. India has launched an integrated response to overcome the unprecedented COVID-19 pandemic, Vardhan added. The Union health minister spoke at the 8th BRICS STI ministerial meeting on Friday. Vardhan said India …
Read More »India To Receive 100 Million Astrazeneca Vaccines By December: Adar Poonawalla
By: Bloomberg | Updated: November 14, 2020 10:58:49 am Laboratory technicians handle capped vials as part of fill and pack testing for large-scale production and delivery of the University of Oxfords COVID-19 candidate vaccine. (Vincenzo Pinto / AFP / Getty Images via Bloomberg) The world’s largest vaccine maker is ramping …
Read More »Markets are already pricing in a successful Moderna vaccine
The stakes are high for the results of Moderna Inc.’s upcoming Covid-19 vaccine trial.But when it comes to investors, the impact may already be on the price of financial assets. The bar was raised for markets to rebound following an announcement by Pfizer Inc. that its vaccine protected 90% of …
Read More »Serum Institute Director Says India Will Receive 100 Million Astra Injections Next Month
The world’s largest vaccine maker is ramping up production of AstraZeneca Plc’s Covid-19 injection, aiming to have 100 million doses ready by December for an inoculation campaign that could begin across India later that month. If data from the final stage of the trial shows that the AstraZeneca candidate provides …
Read More »Coronavirus Vaccine Updates – 40 Million Doses of AstraZeneca COVID-19 Vaccine Produced – Serum Institute of India
The AstraZeneca vaccine is the most advanced in human testing in India. Serum said. Bangalore: The Serum Institute of India, the world’s largest vaccine producer, said Thursday that it has manufactured 40 million doses of AstraZeneca’s potential COVID-19 vaccine and will soon begin producing Novavax’s rival vaccine as both seek …
Read More »Keeping Pfizer Vaccine Below 70 Celsius Is Difficult, Says AIIMS Chief
The announcement of the major American pharmacist Pfizer about the Covid-19 vaccine trial has raised new hope in a world hit by the coronavirus pandemic. Experts, however, point toward the logistics of delivering the potential vaccine to a larger population. One such expert is the director of India’s leading Institute …
Read More »Sputnik V 92% effective against coronavirus, Russia claims
Sputnik V, Russia’s experimental COVID-19 vaccine, is 92% effective in protecting people from coronavirus, based on the results of the interim trial, the Russian Direct Investment Fund (RDIF) said on Wednesday. Interim results are based on data from the first 16,000 trial participants who received both injections of the two-dose …
Read More »